Derivatives of 2-amino-benzoxazine in the treatment of obesity.

2000 
The use of a compound comprising the formula ** ** or a pharmaceutically acceptable salt, ester or amide thereof; in the manufacture of a medicament for the treatment of conditions which require the inhibition of an enzyme whose preferred mode of action is to catalyze the hydrolysis of an ester functionality, wherein said condition or obesity related disorder obesity.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []